The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, including healthcare providers, about Phesgo, a suspected counterfeit cancer treatment drug.
The alert on the circulation of the drug was published on the agency’s website.
NAFDAC said a doctor at the Lagos University Teaching Hospital (LUTH) had raised concerns about the drug after a patient brought it in.
The agency said the product had not been administered, but it matched the characteristics of a previously reported counterfeit batch, C3809C51.
“The National Agency for Food and Drugs Administration and Control (NAFDAC) wishes to inform healthcare providers and the public of a report of a suspected counterfeit Phesgo® 600mg/600mg/10ml, labelled with batch C5290S20,” the statement reads.
“The Marketing Authorisation Holder (MAH) Roche received a complaint from a doctor at Lagos University Teaching Hospital (LUTH-NSIA) reporting a suspected counterfeit Phesgo® 600mg/600mg, labelled with batch C5290S20.
